文献速递心律失常

新发RyR2-R2401H突变致儿茶酚胺敏感性多形性室性心动过速相关反复晕厥

[Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2017-01-01

报告1例中国儿茶酚胺敏感性多形性室性心动过速(CPVT)患者,运动或受惊吓后反复晕厥,静息心电图及超声心动图正常,运动平板试验诱发双向和多形性室性心动过速。基因检测发现RYR2-R2401H新发突变,父母、姐姐及400例对照均未携带。高剂量琥珀酸美托洛尔(118.75 mg/d)治疗有效,随访2年无晕厥发作。

要点

  • 运动或惊吓诱发反复晕厥、静息心电图正常者应行运动平板试验排查CPVT。
  • 本例检出RYR2-R2401H新发突变,父母、姐姐及400例同族对照均未携带。
  • 高剂量琥珀酸美托洛尔(118.75 mg/d)治疗有效,随访2年无晕厥发作。

核心结论

  • 首次报道中国CPVT患者携带RyR2-R2401H突变,高剂量美托洛尔可有效治疗RyR2基因突变所致CPVT。

研究设计与样本

  • 对2013年3月南昌大学第二附属医院心内科收集的1例CPVT患者进行临床资料分析,并行家系成员及400例同族健康对照的候选基因测序。
  • 对RYR2、CASQ2、TRDN、CALM1、KCNJ2及ANKB六个CPVT相关基因的外显子及外显子-内含子交界区进行直接测序。

主要发现

  • 患者因运动或受惊吓后出现反复晕厥,无晕厥及猝死家族史,静息心电图及超声心动图正常。
  • 运动平板试验可诱发双向和多形性室性心动过速。
  • 患者携带RYR2-R2401H突变,其父母、姐姐及400例对照均未携带此突变,余5个候选基因未见突变。
  • 经高剂量琥珀酸美托洛尔(118.75 mg/d)治疗有效,随访2年无晕厥发作。

关键数值与推荐

  • 本例患者检出RYR2-R2401H突变,父母、姐姐及400例同族健康对照均未携带。
  • 高剂量琥珀酸美托洛尔剂量为118.75 mg/d,随访2年无晕厥发作。

临床怎么用

  • 作者认为高剂量美托洛尔可有效治疗RyR2基因突变所致CPVT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the clinical and molecular genetic features of a Chinese patient with catecholaminergic polymorphic ventricular tachycardia (CPVT). Methods: Clinical data including resting electrocardiography, echocardiography and treadmill exercise testing of a patient with CPVT admitted to our department in March 2013 were analyzed, and the peripheral venous blood samples of the patient and his family members and 400 ethnicity-matched healthy controls were obtained. All exons and exon-intron boundaries of the six CPVT-related genes including RYR2, CASQ2, TRDN, CALM1, KCNJ2 and ANKB were sequenced to detect the variants related to CPVT. The relationship between the genotypes and phenotypes was analyzed to direct the target therapy. Results: Recurrent syncope induced either by exercise or extreme frightened fear was observed in this patient. There was no positive family history of syncope or sudden death. The resting electrocardiography and echocardiography of the patient were normal, while the exercise testing revealed bidirectional and polymorphic ventricular tachycardia. A cardiac ryanodine receptor gene mutation (R2401H) was identified in this patient, while this mutation was absent in his parents and sister and 400 controls. No variant was detected in the remaining five candidate genes. Treatment with high dose of metoprolol succinate (118.75 mg/d) was effective and patient was free of syncopal attack during the 2 years follow-up. Conclusion: This is the first report on RyR2-R2401H mutation in Chinese patient with CPVT, and high dose of metoptolol is the effective therapy option for CPVT related to RyR2 mutation. 目的: 探讨1例儿茶酚胺敏感性室性心动过速(CPVT)患者临床和分子遗传学特征。 方法: 对2013年3月南昌大学第二附属医院心内科所收集1例CPVT患者的静息心电图、超声心动图和运动平板试验等临床资料进行分析,并采集患者及其相关家族成员和400例同族健康人外周静脉血样标本,使用DNA直接测序法对6个CPVT致病相关候选基因兰尼碱受体2(RyR2)、集钙蛋白(CASQ2)、TRDN、CALM1、KCNJ2及ANKB的外显子,以及外显子与内含子交界区序列进行直接测序,以筛查CPVT相关基因变异,分析基因型与表现型关系,并指导临床治疗。 结果: 收集到CPVT患者1例,因运动或受惊吓后出现反复晕厥,无晕厥及猝死家族史,静息心电图及超声心动图结果正常,运动平板试验可诱发双向和多形性室性心动过速。遗传检测发现该患者携带CPVT致病基因突变RyR2-R2401H,其父母、姐姐及400例对照中均未携带此突变,余5个候选基因未见突变。患者经高剂量琥珀酸美托洛尔(118.75 mg/d)治疗有效,随访2年无晕厥发作。 结论: 首次报道中国人CPVT相关RyR2-R2401H突变,高剂量美托洛尔可有效治疗RyR2基因突变所致CPVT。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu X, Li JX, Hu JZ, et al. [Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 28100344. doi:10.3760/cma.j.issn.0253-3758.2017.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。